Transition Therapeutics Inc Stock

Stocks

26/08/16	Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	PR
03/06/16	Transition Therapeutics : Receives Notification From NASDAQ	PR
12/05/16	Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	PR
10/05/16	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	PR
18/04/16	Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	PR

1 day

+0.52%

Manager	Title	Age	Since
Antonio F. Cruz CEO	Chief Executive Officer	73	06/07/1998

Director	Title	Age	Since
Antonio F. Cruz CHM	Chairman	73	04/08/2010

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TRANSITION THERAPEUTICS INC	+0.52%	-6.31%	-	-	0
ELI LILLY AND COMPANY	-2.54%	+1.75%	+56.75%	+117.82%	1,165B
JOHNSON & JOHNSON	-1.42%	+4.16%	+36.73%	+72.42%	645B
ABBVIE INC.	+0.16%	+0.79%	+24.91%	+95.34%	504B
ROCHE HOLDING AG	-0.31%	+2.95%	+39.36%	+63.56%	380B
MERCK & CO., INC.	-1.34%	+0.06%	+65.81%	+41.49%	363B
NOVARTIS AG	-0.68%	+1.67%	+22.07%	+50.94%	297B
ASTRAZENECA PLC	-1.20%	+0.99%	+2.26%	+22.95%	269B
AMGEN INC.	-1.79%	+1.20%	+48.41%	+57.55%	237B
GILEAD SCIENCES, INC.	-0.73%	-0.85%	+28.47%	+100.57%	195B
Average	-0.55%	+2.54%	+36.09%	+69.18%	450.61B
Weighted average by Cap.	-0.25%	+3.17%	+40.78%	+80.33%

Employees

Sector